Efficacy and safety of antazoline vs propafenone for conversion of paroxysmal atrial fibrillation to sinus rhythm: a randomized, double-blind study (AnProAF).
Jarosław KarwowskiKarol WrzosekRenata Mączyńska-MazurukKatarzyna SzmarowskaJerzy RekoszAnna WiktorskaBeata MierzejewskaMateusz SoleckiMirosław DłużniewskiPublished in: Polish archives of internal medicine (2024)
Intravenous antazoline demonstrated efficacy and safety comparable to those of intravenous propafenone for acute conversion of nonvalvular paroxysmal AF to sinus rhythm in patients without heart failure.
Keyphrases
- atrial fibrillation
- heart failure
- catheter ablation
- oral anticoagulants
- left atrial
- left atrial appendage
- direct oral anticoagulants
- end stage renal disease
- percutaneous coronary intervention
- high dose
- ejection fraction
- newly diagnosed
- double blind
- clinical trial
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- blood pressure
- randomized controlled trial
- liver failure
- left ventricular
- heart rate
- patient reported outcomes
- coronary artery disease
- hepatitis b virus
- venous thromboembolism
- placebo controlled
- phase ii
- acute coronary syndrome
- mitral valve
- mechanical ventilation